Videos | AHA

DAIC Editor Dave Fornell takes a tour of some of the most innovative new cardiovascular technologies on display on the ...

Home November 19, 2018
Home
News | Cardiovascular Clinical Studies

The U.S. Food and Drug Administration (FDA) is proposing to add an exception to informed consent requirements for certain FDA-regulated clinical investigations that present no more than minimal risk to human research participants.

Home November 19, 2018
Home
Sponsored Content | Videos | Cath Lab

Navin Kapur, M.D., discusses the results of the FDA STEMI Door-to-Unloading (DTU) safety and feasibility randomized ...

Home November 15, 2018
Home
News | Nuclear Imaging

GE Healthcare announced it is recalling its Millennium Nuclear Medicine Systems due to an incident in which the the top detector detached and fell onto the detector below it. No patient injuries have been reported, although there remains a risk of potential life-threatening bodily harm if the detector were to detach and fall during a patient exam. The U.S. Food and Drug Administration (FDA) has identified this as a Class I recall, the most serious type of recall.

Home November 15, 2018
Home
News | Pharmaceuticals

AstraZeneca announced positive full results from the DECLARE-TIMI 58 cardiovascular (CV) outcomes trial (CVOT) for Farxiga (dapagliflozin) as a late-breaking abstract at the American Heart Association (AHA) Scientific Sessions 2018, Nov. 10-12 in Chicago. Results were simultaneously published in the New England Journal of Medicine (NEJM).

Home November 15, 2018
Home
Videos | Heart Failure

James Januzzi, M.D., Hutter Family Professor at Harvard Medical School and a cardiologist at Mass General Hospital ...

Home November 15, 2018
Home
Videos | EP Lab

Wilber Su, M.D., chief of cardiac electrophysiology, Banner University Medical Center, Phoenix, and clinical associate ...

Home November 15, 2018
Home
News | Cardiac Diagnostics

The U.S. Department of Health and Human Services (HHS) released the second edition of the Physical Activity Guidelines for Americans at the American Heart Association’s (AHA) 2018 Scientific Sessions, Nov. 10-12 in Chicago. The second edition — announced at AHA by Adm. Brett P. Giroir, M.D., assistant secretary for health — provides evidence-based recommendations for youth ages three through 17 and adults to safely get the physical activity they need to stay healthy.

Home November 14, 2018
Home
Videos | Artificial Intelligence

James Januzzi, M.D., Hutter Family Professor at Harvard Medical School and a cardiologist at Mass General Hospital ...

Home November 14, 2018
Home
Videos | Computed Tomography (CT)

Matthew Budoff, M.D., professor of medicine, David Geffen School of Medicine, UCLA, spoke at the 2018 American Heart ...

Home November 14, 2018
Home
ACC and AHA Release Updated Cholesterol Guidelines for 2018. #AHA18 #AHA2018
Feature | Cardiac Diagnostics

November 13, 2018 — New cholesterol guidelines from the American Heart Association (AHA) and the American College of ...

Home November 13, 2018
Home
Videos | Pharmaceuticals

Deepak L. Bhatt, M.D., executive director of the interventional cardiovascular program, Brigham and Women’s Hospital ...

Home November 13, 2018
Home
News | Pharmaceuticals

A study in the current edition of the New England Journal of Medicine shows that a particular treatment significantly reduced cardiovascular events, including cardiovascular death, in patients who continue to have high triglyceride levels on statin therapy. These findings could lead to a more effective and life-saving treatment option when used with other combinations of drugs to treat cardiovascular disease.

Home November 13, 2018
Home
News | Hypertension

Black adults experience dangerous spikes in high blood pressure, called a hypertensive crisis, at a rate that is five times the national average, according to a new study. The study was presented at the American Heart Association’s (AHA) Joint Hypertension 2018 Scientific Sessions, an annual conference focused on recent advances in hypertension research, Sept. 6-9 in Chicago.

Home November 13, 2018
Home
News | Vascular Closure Devices

The Vascade MVP vascular closure system met its endpoints compared to manual compression in a pivotal clinical study for multi-access venous closure following electrophysiology (EP) procedures, according to manufacturer Cardiva Medical Inc. The AMBULATE study is the first randomized pivotal trial of vessel closure conducted exclusively by EP physicians.

Home November 11, 2018
Home
Subscribe Now